The Congressionally Directed Medical Research Programs (CDMRP) established the Tick-Borne Disease Research Program (TBDRP) to advance high-impact discovery in the prevention, diagnosis, treatment, and long-term understanding of tick-borne illnesses. These conditions—which include Lyme disease, ehrlichiosis, anaplasmosis, babesiosis, Rocky Mountain spotted fever, and a rapidly expanding set of emerging pathogens—remain a growing public health concern. Service members are frequently deployed or trained in wooded, humid, or rural environments in the U.S. and abroad where tick exposure risk is significantly elevated. Tick-borne disease affects force readiness, return-to-duty rates, musculoskeletal endurance, cognitive performance, and long-term health outcomes, making this research area particularly significant for military medicine. 

The TBDRP portfolio funds mechanistic, translational, clinical, epidemiological, and surveillance research designed to improve early detection, guide treatment decisions, reduce disease progression, and prevent chronic or recurrent infection. Research priorities include novel biomarker identification, minimally invasive diagnostics, next-generation imaging or molecular detection platforms, and adaptive testing systems capable of distinguishing co-infections, disease stage, persistence, or treatment response. Because many tick-borne conditions share overlapping symptoms with autoimmune, neurological, cardiac, rheumatologic, or chronic fatigue presentations, early diagnostic clarity remains a central priority for TBDRP award mechanisms. 

In addition to diagnostics, the program supports therapeutic innovation, including antimicrobial optimization, host-directed therapies, immunomodulation, combinatorial approaches, and translational research capable of addressing persistent infection or treatment-refractory disease. TBDRP also encourages precision surveillance, exposure forecasting, vector ecology research, and public health modeling that improve military field response, geographic risk assessment, and prevention strategies for at-risk units. 

A major emphasis involves bridging clinical gaps: understanding long-term sequelae, improving rehabilitative outcomes, strengthening neurocognitive assessment following infection, and evaluating chronic inflammatory or autoimmune consequences of tick-borne illness in military and civilian populations. Investigators may also pursue digital medicine, wearable monitoring, mobile diagnostics, or telehealth-ready clinical tools that enhance access to care among dispersed service members and families living near training locations or high-risk geographies. 

Because tick-borne pathogens evolve rapidly and new species are detected each year, TBDRP maintains a flexible, milestone-driven framework to accelerate high-risk, high-reward innovation that conventional funding pathways may not prioritize. Multidisciplinary collaboration is strongly encouraged, bringing together microbiologists, immunologists, infectious disease physicians, rehabilitation experts, neurologists, epidemiologists, ecologists, computational biologists, and public health researchers to ensure rapid translation from laboratory insight to clinical benefit. 

As geographic expansion, climate effects, civilian–military interface, and shifting vector ecology increase exposure pressure, the CDMRP Tick-Borne Disease Research Program plays a crucial role in advancing prevention, early detection, risk mitigation, and therapeutic optimization for service members, veterans, and affected military families. 

ScienceDocs Can Help 

ScienceDocs has over two decades of experience supporting competitive DoD infectious disease, surveillance, epidemiology, and translational medicine proposals, including TBDRP submissions. We assist with exploratory framing, mechanism alignment, milestone definition, biomarker strategy, experimental design, and full proposal writing with production-ready formatting. To begin a conversation or receive a formal cost estimate, please visit: https://www.sciencedocs.com/quotes